Wilmot Cancer Institute Re-certified by Prestigious National Quality Improvement Program
UR Medicine’s Wilmot Cancer Institute has received reaccreditation by the Quality Oncology Practice Initiative (QOPI) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO). The QOPI Certification Program (QCP) provides a three-year certification for outpatient hematology-oncology practices that meet nationally recognized standards for quality cancer care.
Wilmot Cancer Institute is the only QOPI-certified cancer care provider in the Rochester and Finger Lakes region.
“This recertification is a testament to our commitment to providing high-quality care for patients at all of our locations,” said David W. Dougherty, M.D., M.B.A., Chief Quality & Safety Officer at Wilmot Cancer Institute. “The QOPI Certification Program has been a great opportunity for us to measure against national benchmarks and to find ways that we can continue elevating our practice.”
The QOPI certification applies to all Wilmot Cancer Institute sites that offer hematology and oncology services, including Geneva, Highland Hospital, Park Ridge, Pluta Cancer Center, Sands Cancer Center, Strong West and the James P. Wilmot Cancer Center at Strong Memorial Hospital. UR Medicine’s Division of Hematology/Oncology, based at Wilmot Cancer Center, initially achieved this certification in March 2012.
“Our vision is to provide the highest quality, precision cancer care throughout our region,” said Jonathan W. Friedberg, M.D., M.M.Sc., director of Wilmot Cancer Institute. “The QOPI recertification is tangible evidence of our dedication to patient safety and our commitment to meeting stringent national standards at all of our locations.”
To become certified, practices have to submit to an evaluation of their entire practice and documentation standards. The QCP staff and steering group members then verify through on-site inspection that the evaluation and documents are correct and that the practices meet core standards in areas of treatment, including:
- treatment planning;
- staff training and education;
- chemotherapy orders and drug preparation;
- patient consent and education;
- safe chemotherapy administration;
- monitoring and assessment of patient well-being.
The QCP is a project of ASCO’s Institute for Quality, an ASCO affiliate dedicated to innovative quality improvement programs. For more information, please visit http://qopi.asco.org/certification.html.
About ASCO: Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 35,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit www.asco.org. Patient-oriented cancer information is available at www.cancer.net.
About ASCO Institute for Quality, LLC: The ASCO Institute for Quality is an ASCO affiliate dedicated to innovative quality improvement programs for ASCO members and their patients. Committed to providing oncologists with the necessary resources to provide every patient with high-level cancer care, the Institute carries out ASCO’s clinical quality improvement programs. The Institute is a wholly-owned subsidiary of ASCO.
About Wilmot Cancer Institute: UR Medicine’s Wilmot Cancer Institute is the Finger Lakes region’s leader for cancer care and research. As a component of Strong Memorial Hospital, Wilmot Cancer Institute provides specialty cancer care services at the University of Rochester Medical Center and a network of locations throughout the region. The Institute also includes a team of 100 scientists who investigate many aspects of cancer, with an emphasis on how best to provide precision cancer care. To learn more, visit wilmot.urmc.edu.